Shipra Gandhi1, Fumito Ito2,3, Marc S Ernstoff1. 1. Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. 2. Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA. 3. Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA.
Authors: K Vuoriluoto; H Haugen; S Kiviluoto; J-P Mpindi; J Nevo; C Gjerdrum; C Tiron; J B Lorens; J Ivaska Journal: Oncogene Date: 2010-11-08 Impact factor: 9.867
Authors: Laurence Wurth; Panagiotis Papasaikas; David Olmeda; Nadine Bley; Guadalupe T Calvo; Santiago Guerrero; Daniela Cerezo-Wallis; Javier Martinez-Useros; María García-Fernández; Stefan Hüttelmaier; Maria S Soengas; Fátima Gebauer Journal: Cancer Cell Date: 2016-10-27 Impact factor: 31.743
Authors: Joanne R Evans; Sally A Mitchell; Keith A Spriggs; Jerzy Ostrowski; Karol Bomsztyk; Dirk Ostarek; Anne E Willis Journal: Oncogene Date: 2003-09-11 Impact factor: 9.867